Produkty 1206164-58-0

CAS 1206164-58-0 występuje w naszej ofercie pod nazwami: 6-Alpha-Hydroxy Stanozolol, >95% (HPLC), 6-a-Hydroxy Stanozolol, >95% (HPLC), 6-Alpha-Hydroxy Stanozolol (1.0mg/ml in Methanol), 6-Alpha-hydroxy stanozolol - controlled substance. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 2,5mg, 25mg, 1x1ml, 10mg, 50mg.

6-Alpha-Hydroxy Stanozolol, >95% (HPLC)
TRC
  • opakowanie: 2,5mg
  • Warianty: 1
Zobacz produkt
6-a-Hydroxy Stanozolol, >95% (HPLC)
TRC
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
6-Alpha-Hydroxy Stanozolol (1.0mg/ml in Methanol)
TRC
  • opakowanie: 1x1ml
  • Warianty: 1
Zobacz produkt
6-Alpha-hydroxy stanozolol - controlled substance
Biosynth
  • opakowanie: 25mg, 10mg, 50mg
  • Warianty: 3
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(1S,2R,10S,11S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-diene-11,17-diol (CAS 1206164-58-0) to związek chemiczny o wzorze sumarycznym C21H32N2O2 i masie molowej 344.5 g/mol. Nazwa systematyczna IUPAC: (1S,2R,10S,11S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-diene-11,17-diol. InChIKey: ZGXUFMUEOXDZPA-ZQQWDGOHSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H32N2O2
Masa molowa344.5 g/mol
Nazwa IUPAC(1S,2R,10S,11S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-diene-11,17-diol
InChIKeyZGXUFMUEOXDZPA-ZQQWDGOHSA-N
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)C[C@@H]([C@@H]4[C@@]3(CC5=C(C4)NN=C5)C)O

Dane obliczone przez PubChem (NCBI)

Izomery (ten sam wzór sumaryczny)
(1S,5aR,9aR,11aS)-N,N,9a,11a-tetramethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide C21H32N2O2
tert-butyl 4-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]piperidine-1-carboxylate C21H32N2O2
(1S,2S,10S,13R,14S,17S,18S)-17-hydroxy-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icos-4(8)-en-5-one C21H32N2O2
(1S,2S,10S,13R,14S,17S,18S)-16,16-dideuterio-17-hydroxy-2,18-dimethyl-17-(trideuteriomethyl)-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icos-4(8)-en-5-one C21H32N2O2
(1S,2R,9S,10R,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-diene-9,17-diol C21H32N2O2
(1S,2S,10S,13R,14S,16S,17R,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-diene-16,17-diol C21H32N2O2
(1S,2R,9R,10R,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-diene-9,17-diol C21H32N2O2
(2R,10S,11R,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4,6-diene-11,17-diol C21H32N2O2
[(3S,8R,9S,10R,13S,14S,17E)-17-hydrazinylidene-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H32N2O2
(1S,2S,10S,13R,14S,17S,18S)-17-hydroxy-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icos-4(8)-en-5-one C21H32N2O2
tert-butyl 9-benzyl-3,9-diazaspiro[5.5]undecane-3-carboxylate C21H32N2O2